Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Forian has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Forian achieved revenue of $20.2M and an EBITDA of -$2.9M.
Forian expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Forian valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $20.5M | $20.2M | XXX | XXX | XXX |
Gross Profit | $21.1M | $15.0M | XXX | XXX | XXX |
Gross Margin | 103% | 74% | XXX | XXX | XXX |
EBITDA | $2.8M | -$2.9M | XXX | XXX | XXX |
EBITDA Margin | 13% | -14% | XXX | XXX | XXX |
Net Profit | -$26.0M | $11.1M | XXX | XXX | XXX |
Net Margin | -127% | 55% | XXX | XXX | XXX |
Net Debt | $21.8M | $18.8M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Forian's stock price is $2.
Forian has current market cap of $61.0M, and EV of $32.6M.
See Forian trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$32.6M | $61.0M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Forian has market cap of $61.0M and EV of $32.6M.
Forian's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Forian's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Forian and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $32.6M | XXX | XXX | XXX |
EV/Revenue | 1.6x | XXX | XXX | XXX |
EV/EBITDA | -11.2x | XXX | XXX | XXX |
P/E | -16.2x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | 115.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpForian's NTM/LTM revenue growth is n/a
Forian's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.5M for the same period.
Over next 12 months, Forian's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Forian's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Forian and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | -2% | XXX | XXX | XXX | XXX |
EBITDA Margin | -14% | XXX | XXX | XXX | XXX |
EBITDA Growth | -206% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.5M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.5M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 22% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 62% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 7% | XXX | XXX | XXX | XXX |
Opex to Revenue | 91% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
Echo IQ | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Forian acquired XXX companies to date.
Last acquisition by Forian was XXXXXXXX, XXXXX XXXXX XXXXXX . Forian acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Forian founded? | Forian was founded in 2014. |
Where is Forian headquartered? | Forian is headquartered in United States of America. |
How many employees does Forian have? | As of today, Forian has 37 employees. |
Who is the CEO of Forian? | Forian's CEO is Mr. Max C. Wygod. |
Is Forian publicy listed? | Yes, Forian is a public company listed on NAS. |
What is the stock symbol of Forian? | Forian trades under FORA ticker. |
When did Forian go public? | Forian went public in 2021. |
Who are competitors of Forian? | Similar companies to Forian include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere. |
What is the current market cap of Forian? | Forian's current market cap is $61.0M |
What is the current revenue growth of Forian? | Forian revenue growth between 2023 and 2024 was -2%. |
Is Forian profitable? | Yes, Forian is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.